ADS most commonly occurs with SSRIs and SNRIs, particularly shorter half-life medications like paroxetine and venlafaxine
Antidepressant Discontinuation Syndrome in La Crosse, WI: Support for Coming Off Medication and What Comes Next
Antidepressant discontinuation syndrome is real, recognized, and often poorly managed. IV ketamine therapy and Spravato offer a neurologically distinct alternative for people navigating the difficult territory of stopping antidepressants, whether because of side effects, ineffectiveness, or a desire to find a different path forward.
What You're Experiencing Is Real. And You Deserve Better Than Being Told to Just Wait It Out.
Antidepressant discontinuation syndrome occurs when someone stops or significantly reduces their antidepressant dose too quickly. The symptoms, which can include dizziness, nausea, electric shock sensations known as brain zaps, intense mood swings, anxiety, and a return or worsening of depression, can range from uncomfortable to genuinely debilitating. Yet for many patients, they’re dismissed or minimized by the same healthcare system that prescribed the medication in the first place.
At Relevate Ketafusion, we take this experience seriously. We work with people who are navigating the difficult territory of coming off antidepressants for a range of reasons: the medication stopped working, the side effects became intolerable, or they want to explore whether a different treatment approach can provide better long-term relief. IV ketamine and Spravato work on an entirely different neurological pathway than SSRIs and SNRIs, making them a genuinely distinct option rather than just another variation on the same mechanism.
We’re not anti-medication. We’re pro-options. If antidepressants have worked well for you, that’s the right path. If they haven’t, or if stopping them has created a new set of problems, we may be able to help.
Understanding Antidepressant Discontinuation Syndrome
Antidepressant discontinuation syndrome, sometimes called antidepressant withdrawal, occurs because the brain adapts to the presence of antidepressant medication over time. When the medication is removed too quickly, the brain’s serotonin and norepinephrine systems need time to recalibrate. That recalibration period produces symptoms that can feel alarming and that are frequently mistaken for a relapse of the original depression.
ADS most commonly occurs with SSRIs and SNRIs, particularly those with shorter half-lives like paroxetine and venlafaxine. Symptoms typically begin within a few days of stopping or significantly reducing the dose and can last anywhere from a few weeks to several months in more severe cases. The FINISH mnemonic describes the core symptoms: Flu-like symptoms, Insomnia, Nausea, Imbalance and dizziness, Sensory disturbances including brain zaps, and Hyperarousal including anxiety and irritability.
A critical clinical challenge is distinguishing ADS from a genuine relapse of the underlying depression. Both can produce low mood, anxiety, and difficulty functioning. The timeline, the specific symptom profile, and the context of the medication change all matter for making that distinction accurately. Our team will help you think through this carefully during your consultation.
Hear from Those Who've Found Hope
Call us
(608) 518-3915Address
2309 State Road La Crosse, WI 54601
Working hours
Mon-Thu: 7:30 am - 7:30 pm
Fri-Sat: 7:30 am - 12:30 pm
Book Your Consultation
Fill out the form below, and we’ll contact you shortly.
How We Can Help: What Ketamine Therapy Offers in This Context
It's important to be clinically honest here: ketamine therapy and Spravato don't treat antidepressant discontinuation syndrome itself. The physical symptoms of ADS, including brain zaps, dizziness, and nausea, are a neurological adjustment process that resolves as the brain recalibrates. What ketamine and Spravato can address is what comes before, during, and after that process.
Depression That Returns After Stopping Antidepressants
For many people, coming off antidepressants reveals that the underlying depression was being managed but not resolved. When the medication is removed, depression returns, sometimes more intensely than before. This isn't a failure. It's information: serotonin-targeting medication may not be addressing the root of the problem. Ketamine and Spravato target the glutamate system, offering a neurologically distinct approach that may produce more durable relief for people whose depression hasn't been adequately addressed by SSRIs or SNRIs.
Treatment-Resistant Depression After Multiple Antidepressant Trials
For patients who have tried multiple antidepressants and found them either ineffective or intolerable, treatment-resistant depression is the clinical picture. Both IV ketamine and Spravato were developed for exactly this population. Spravato carries an FDA approval for treatment-resistant depression defined as inadequate response to at least two antidepressants, and it's covered by most major insurance plans.
Anxiety During Antidepressant Discontinuation
Anxiety is one of the most disruptive symptoms of ADS, often showing up as hyperarousal, irritability, and a generalized sense of distress that's difficult to manage without medication. Ketamine therapy's rapid calming effect on overactive neural circuits can provide meaningful relief during this difficult transition period, giving the nervous system support while the serotonin system recalibrates.
Wanting a Different Long-Term Treatment Approach
Some people stop antidepressants not because of failure or side effects, but because they want to explore whether a different approach might offer more complete or more sustainable relief. Ketamine therapy and Spravato work on entirely different neurological pathways, making them a genuinely new direction rather than a variation on what's been tried. Our team will help you assess honestly whether that makes sense for your specific situation.
Your Treatment Journey at Relevate Ketafusion
From your first conversation to your last session, we're with you at every step.
01
Initial Consultation
Your journey starts with a virtual consultation. We'll talk through your antidepressant history, your current symptoms, what's driven the decision to come off medication or explore alternatives, and what you're hoping to find. We'll be direct about what ketamine therapy can and can't offer in your specific situation, and we'll help you make an informed decision with full context. No commitment required.
02
Personalized Treatment Plan
We build your plan around your specific diagnosis, medication history, and goals. If you're in the middle of antidepressant discontinuation, we'll discuss timing carefully to ensure ketamine therapy is introduced at the right point in that process. We'll coordinate with your prescribing provider where appropriate and set clear expectations for timeline, session frequency, and how we'll track your progress.
03
Treatment Sessions
Every session takes place in a private, calm treatment room with ambient lighting and soothing music. Our medical team stays present throughout, monitoring your vitals and your comfort in real time. Most patients describe the experience as peaceful. Plan to have someone drive you home afterward.
04
Integration and Ongoing Monitoring
We monitor your response carefully and adjust your plan as needed. For patients transitioning away from antidepressants, we pay particular attention to the trajectory of mood, anxiety, and functioning over time, distinguishing genuine progress from the natural fluctuations of the discontinuation period. After your initial series, we'll develop a maintenance approach that supports your long-term stability.
Our Treatments: IV Ketamine and Spravato
We offer two clinically validated, rapid-acting treatments that work on entirely different neurological pathways than SSRIs and SNRIs. Your provider will help determine the right fit based on your history, current situation, and goals.
IV Ketamine Therapy
Administered directly into the bloodstream through a small IV line, ketamine infusions offer precise dosing and immediate effect. Sessions typically last 40 to 60 minutes in a private, calm treatment room with continuous medical supervision. IV ketamine acts on glutamate and NMDA receptors, a completely different mechanism than SSRIs, producing rapid antidepressant effects that don't require the weeks of build-up that conventional antidepressants need. It's a self-pay treatment and not covered by insurance.
Learn More
Spravato (Esketamine) Therapy
FDA-approved for treatment-resistant depression and MDD with suicidal ideation, Spravato is derived from ketamine but administered as a nasal spray in our clinic under direct medical supervision. Importantly, Spravato is used in conjunction with an oral antidepressant per its approved protocol, so it may be part of a transition strategy rather than a complete departure from antidepressant therapy. Clinical studies show no known withdrawal syndrome from Spravato itself, which is a meaningful difference from SSRI and SNRI discontinuation. Spravato is covered by most major insurance plans.
Learn More
The Science: Why Ketamine Works Differently Than Antidepressants
SSRIs and SNRIs work by increasing the availability of serotonin and norepinephrine in the brain. They require weeks to reach therapeutic levels and produce physical dependence in the serotonin system over time, which is why stopping them too quickly produces discontinuation symptoms. Ketamine and Spravato work on an entirely different pathway.
By targeting glutamate and NMDA receptors, ketamine triggers rapid synaptic growth and neural plasticity. It doesn’t build up gradually. It works within hours. And critically, clinical studies of Spravato found no distinct withdrawal syndrome following cessation, which stands in meaningful contrast to the SSRI and SNRI discontinuation experience that brings many patients to our door.
For people whose depression has been managed but not resolved by antidepressants, the glutamate pathway may be the missing piece: a neurological route that serotonin-targeting medications simply don’t address.
Why Choose Relevate Ketafusion
01
A Team That Understands the Full Clinical Picture
Navigating antidepressant discontinuation while managing underlying depression and anxiety requires careful clinical judgment. Dr. Schumaker’s dual board certifications in Family and Emergency Medicine and chemical engineering background mean he understands psychotropic medications at a molecular level. Robyn Brown’s dual FNP and PMHNP certifications mean she approaches this work with both medical and psychiatric depth.
02
Honest About What Ketamine Can and Can't Do Here
We won’t oversell ketamine for antidepressant discontinuation syndrome. The physical symptoms of ADS resolve with time and tapering support, not ketamine. What we can offer is a genuinely different treatment path for the depression and anxiety that drive the need for antidepressants in the first place, and we’ll tell you honestly whether that makes sense for your situation.
03
The Only IV Ketamine Clinic in the Coulee Region
Relevate Ketafusion is the only provider in the La Crosse area offering IV ketamine infusions. The nearest alternative is over two hours away. We built this clinic so that people in our community could access this level of care without a burdensome drive.
04
Spravato Covered by Insurance
Spravato is covered by most major insurance plans for treatment-resistant depression. Our team verifies your coverage before your first session and handles prior authorization. For IV ketamine, transparent self-pay pricing is available with HSA/FSA acceptance and CareCredit financing.
05
Continuous Medical Supervision at Every Session
Every session happens under direct medical supervision with continuous monitoring. You’re never alone, and our team stays present and attentive throughout every visit.
06
Founded by Someone Who Knows What It Means to Need a Different Answer
Tina Schumaker built Relevate after her own experience with treatment-resistant depression and PTSD. She knows what it feels like to keep trying what’s available and still not feel better. That experience is the reason this clinic exists, and it shapes how we approach every patient who comes through our doors looking for something different.
Blogs
Insights & Resources
Explore articles that empower your path to wellness.
March 25, 2026
Hope Beyond Traditional Antidepressants: Exploring New Paths to Healing
March 18, 2026
The Role of Integration After Ketamine Sessions
March 11, 2026
Understanding Dissociation: Why Some People Experience It and How It Is Managed During Treatment